Quest Diagnostics DGX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $11.28B+11.0% | $11.04B+11.8% | $10.85B+13.7% | $10.52B+12.6% | $10.16B+9.4% | ||
| $7.53B+10.4% | $7.37B+11.2% | $7.24B+12.8% | $7.05B+12.2% | $6.82B+9.4% | ||
| $3.74B+12.2% | $3.67B+13.0% | $3.61B+15.7% | $3.48B+13.4% | $3.34B+9.3% | ||
| 33.2%+0.4pp | 33.2%+0.4pp | 33.3%+0.6pp | 33%+0.2pp | 32.8%0.0pp | ||
| $2B+10.5% | $1.97B+11.1% | $1.93B+12.7% | $1.88B+14.2% | $1.81B+9.9% | ||
| $152M+10.9% | $154M+21.3% | $154M+31.6% | $147M+31.3% | $137M+23.4% | ||
| $12M— | $12M— | —— | —— | —— | ||
| $9.67B+10.3% | $9.48B+11.2% | $9.32B+12.5% | $9.05B+11.9% | $8.77B+9.2% | ||
| $1.61B+15.6% | $1.56B+15.6% | $1.53B+22.3% | $1.48B+16.7% | $1.39B+10.7% | ||
| 14.3%+0.6pp | 14.1%+0.5pp | 14.1%+1.0pp | 14%+0.5pp | 13.7%+0.2pp | ||
| -$260M-15.6% | -$264M-31.3% | -$265M-50.6% | -$248M-48.5% | -$225M— | ||
| -$233M-12.6% | -$238M-39.2% | -$244M-75.5% | -$220M-48.6% | -$207M-50.0% | ||
| $28M-3.4% | $42M+121% | $40M+81.8% | $38M+72.7% | $29M0.0% | ||
| $1.38B+16.1% | $1.32B+12.2% | $1.29B+15.6% | $1.26B+12.5% | $1.19B+5.9% | ||
| $329M+23.7% | $314M+15.0% | $301M+22.9% | $289M+16.5% | $266M+6.8% | ||
| $1.02B+14.2% | $992M+13.9% | $969M+15.2% | $950M+13.1% | $897M+6.0% | ||
| 9.1%+0.2pp | 9%+0.2pp | 8.9%+0.1pp | 9%0.0pp | 8.8%-0.3pp | ||
| $9.05+14.4% | $8.75+13.8% | $8.52+14.5% | $8.35+12.7% | $7.91+6.5% | ||
| $9.17+14.5% | $8.87+14.0% | $8.64+14.9% | $8.47+12.9% | $8.01+6.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$260M-15.6% | -$264M-31.3% | -$265M-50.6% | -$248M-48.5% | -$225M— | ||
| $152M+10.9% | $154M+21.3% | $154M+31.6% | $147M+31.3% | $137M+23.4% | ||
| $27M+50.0% | $26M-13.3% | $21M-43.2% | $28M+47.4% | $18M-18.2% | ||
| $12M— | $12M— | —— | —— | —— | ||
| $11.28B+11.0% | $11.04B+11.8% | $10.85B+13.7% | $10.52B+12.6% | $10.16B+9.4% | ||
| $2.19B+14.5% | $2.13B+15.6% | $2.09B+21.6% | $2.02B+17.5% | $1.91B+12.0% | ||
| 19.4%+0.6pp | 19.3%+0.6pp | 19.3%+1.3pp | 19.2%+0.8pp | 18.8%+0.4pp | ||
| $1.61B+15.6% | $1.56B+15.6% | $1.53B+22.3% | $1.48B+16.7% | $1.39B+10.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Quest Diagnostics's revenue?
- Quest Diagnostics (DGX) generated $11.3B in revenue over the trailing twelve months, up 11.0% year over year.
- Is Quest Diagnostics profitable?
- Quest Diagnostics reported $1.0B in net income over the trailing twelve months, a 9.1% net margin.
- What are Quest Diagnostics's profit margins?
- Gross margin is 33.2% and operating margin is 14.3%, with a 9.1% net margin.
- What is Quest Diagnostics's earnings per share?
- Quest Diagnostics's diluted EPS over the trailing twelve months is $9.05.
- Where does Quest Diagnostics's income statement data come from?
- Every line is extracted from Quest Diagnostics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
